PREPARING LIVE MICROBIAL SAMPLES AND MICROORGANISMS FOR SUBSEQUENT MASS SPECTROMETRIC MEASUREMENT AND EVALUATION

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF ANTICANCER DRUG RESISTANCE

Preparing live microbial samples and microorganisms for subsequent mass spectrometric measurement and evaluation

INHIBITORS OF CHI3L1 AND THEIR USES

Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

Methods for isolating microbial cells from a blood sample

ENHANCING T-CELL FUNCTION AND TREATING A T-CELL DYSFUNCTIONAL DISORDER WITH A COMBINATION OF AN LSD INHIBITOR AND A PD-1 BINDING ANTAGONIST

METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE

METHODOLOGY FOR REAL-TIME VISUALIZATION OF GENOMICS-BASED ANTIBIOTIC RESISTANCE PROFILES

DIAGNOSTIC METHOD

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

Preparing live microbial samples and microorganisms for subsequent mass spectrometric measurement and evaluation

Method for screening, isolating and purifying analytes

Analysis method and β-lactam antibiotic resistance evaluation method

Combination therapies and methods of use thereof

USES OF BIOACTIVE LIPIDS

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

COMPOSITION AND METHOD FOR TREATING INFECTIONS CAUSED BY VANCOMYCIN-RESISTANT INFECTIOUS AGENTS IN A SUBJECT

Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID

CD247 as a biomarker for assessing the effect of chemotherapeutic and biological drugs

Methods and systems for predicting drug-response

Bcl-2-like protein 11 SRM/MRM assay

Identification of methicillin resistant (MRSA)

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Transgenic model for delay-type hypersensitivity (DTH) and use thereof

METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS

Treatment-induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins

Methods for the identification, assessment, and treatment of patients with cancer therapy

Functional assay for cancer recurrence and malignant potential

METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE

Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics

Using Adaptive Immunity to Detect Drug Resistance

Antibodies that specifically bind alpha toxin and methods of use

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles

Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles

Use of stathmin as a biomarker of drug response to furazanobenzimidazoles

Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists

Processes and kits for determining multi-drug resistance of cells

BCL-2-like protein 11 SRM/MRM assay

Novel binding site of IKK-beta

MASS SPECTROMETRIC MEASUREMENT OF B-LACTAMASE RESISTANCES

Diagnostic marker for effect of anticancer agent

Methods to predict and prevent resistance to taxoid compounds

Methods for the identification, assessment, and treatment of patients with cancer therapy

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

INHIBITORS OF THE MUTANT FORM OF KIT

Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists

Methods for predicting and treating tumors resistant to drug, immunotherapy and radiation

Immunochromatography detection of multidrug-resistant and diagnostic kit

PROCESS FOR TUMOUR CHARACTERISTIC AND MARKER SET IDENTIFICATION, TUMOUR CLASSIFICATION AND MARKER SETS FOR CANCER

Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1

Processes and kits for determining multi-drug resistance of cells

Methods and Kits for Direct Detection and Susceptibility Profiling of Beta-Lactam Resistant Bacteria

METHOD FOR JUDGING SUSCEPTIBILITY OF CANCER CELLS TO ANTHRACYCLINE ANTICANCER AGENT AND COMPUTER PROGRAM

Method of reversing carboplatin resistance by inhibition of HGFIN

GENE EXPRESSION PROFILE THAT PREDICTS OVARIAN CANCER SUBJECT RESPONSE TO CHEMOTHERAPY

METHODS AND COMPOSITIONS FOR DETECTING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY

Method of predicting chemotherapeutic responsiveness of cancer

Collecting ovarian cancer stem cells from ovarian cancer cells

Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease

Fibrinogen alpha and hemoglobin polypeptides as cancer markers

IMMUNOCHROMATOGRAPHY DETECTION OF MULTIDRUG-RESISTANT STAPHYLOCOCCUS AND DIAGNOSTIC KIT

Inhibitors of the mutant form of kit

Quantitative Assays for Ras p21 in Body Fluids

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY

Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists

CIRCULATING VE-CADHERIN AS A PREDICTIVE MARKER OF SENSITIVITY OR RESISTANCE TO ANTI-TUMORAL TREATMENT AND IMPROVED METHOD FOR THE DETECTION OF SOLUBLE PROTEINS

Microorganism Detection Method and Apparatus

METHOD FOR PREDICTION OF THE EFFICACY OF VASCULARIZATION INHIBITOR

Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation

Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof

CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereof

METHODS TO DETERMINE THE RESPONSIVENESS TO CISPLATIN TREATMENT

METHOD FOR DETERMINING TRANSPORT ACTIVITY OF A TRANSPORT PROTEIN

GRP78 as a Predictor of Responsiveness to Therapeutic Agents

METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID

Methods to predict and prevent resistance to taxoid compounds

Drug resistance and methods of reversing

METHODS AND COMPOSITIONS RELATING TO EXPRESSION FACTORS

Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications

Detection of Inducible Resistance to Macrolide-Lincosamide-Streptogramin b

Methods of treating infection

Breast cancer resistance protein (BCRP) antibodies

Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof

EARLY DIAGNOSIS AND TREATMENT OF DRUG RESISTANCE IN MUC1-POSITIVE CANCER

HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease

Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury

Predictive and therapeutic markers in ovarian cancer

Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells

Assay and kit for drug efflux transporter activity

Method for determining the efficacy of an anthracycline anticancer agent

IDENTIFICATION OF A CONSTITUTIVELY RESISTANT CANCER STEM CELL

CONSTITUTIVELY RESISTANT CANCER STEM CELLS IN DIAGNOSIS

Inhibitors of the mutant form of kit

Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance

Modulating SOS response induction by antimicrobial agents

Molecular diagnostic method of a cancer tissue or a cancer cell

Mrp3 genes and uses thereof

Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism

Methods for the identification, assessment, and treatment of patients with cancer therapy

Method for detecting multi-drug resistance

Reagents and methods for predicting drug resistance

Tubulin isotype screening in cancer therapy using hemiasterlin analogs

Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease

Breast cancer resistance protein (BCRP) and the DNA which encodes it

Methods and compositions relating to expression factors

Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease